Thursday, October 30, 2008

IMS - will emerging markets make up for US?

The world pharmaceutical market should grow at the same rate (4.5%-5.5%) next year as it has in 2008, but the USA can expect a slowdown. These are the findings of the annual forecast released by IMS Health, which says that global drug sales in 2009 will top $820 billion. However that will be thanks to sustained double-digit growth in key emerging countries offsetting a slower pace in more established markets.

More

No comments: